New initiative to tackle the problems of bladder cancer diagnosis and treatment with photonics
A multi-disciplinary team of European scientists has launched a new research programme to develop an innovative medical imaging system enabling earlier diagnosis and improved monitoring of bladder cancer treatment.
Motivated by recent breakthroughs in multi-photon imaging, the AMPLITUDE project will develop microscopy and endoscopy platforms that exploit novel lasers in combination with state-of-the-art imaging and optical analyses technologies to address the poor reliability and accuracy of cancer diagnosis and monitoring.
The AMPLITUDE team will create unique lasers to generate light in previously unavailable infra-red regions and penetrate much deeper into tissue, where the early signs of cancer often lie undetected. By combining the lasers with multiple detection techniques, the integrated imaging platform, for use in microscopy or endoscopic probes, will be able to capture high-resolution images at depths up to 10 times greater than existing clinical diagnostic tools. Increasing the resolution and penetration depth will enable doctors to carry our faster and more accurate identification and monitoring of bladder tumours, helping to more reliably diagnose and treat patients at an earlier stage. Furthermore, the innovative medical imaging system developed within AMPLITUDE has the potential for application beyond the field of bladder cancer. Successful demonstration within this project will support the development of this technology for the diagnosis and monitoring of other cancers in the future.
The international AMPLITUDE project group includes researchers from the PREIN partner Tampere University group lead by Dr. Regina Gumenuyk. Other partners include high-level research groups from European Universities and companies. The project is an initiative of the Photonics Public Private Partnership, www.photonics21.org and has received funding from the European Union’s Horizon 2020 research and innovation programme.